Data as of Dec 06
| +0.63 / +3.98%|
The 3 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 13.00. The median estimate represents a -2.74% decrease from the last price of 16.45.
The current consensus among 4 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.